| ［1］Szymanka J, Virolainen M, Tarkkanen M, et al. Overrepresentation of lq2123 and 12q1321 in lipomalike liposarcomas but not in benign lipomas:a comparative genomic hybridization study［J］. Cancer Genet Cytogenet,1997, 99 (1): 1418.
［2］Suijkerbuijk RF, Olde Weghuis DE, Van den Berg M,et al. Comparative genomic hybridization as a tool to define two distinct chromosome 12derived amplification units in welldifferentiated liposarcomas［J］. Genes Chromosomes Cancer, 1994, 9(4):292295.
［3］Fritz B, Schubert F, Wrobel G, et al. Microarraybased copy number and expression profiling in dedifferentiated and pleomorhic liposarcoma［J］. Cancer Res, 2002, 62(11): 29932998.
［4］Pedeutour F, Forus A, Coindre JM, et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors［J］. Genes Chromosomes Cancer, 1999, 24(1):3041.
［5］Pilotti S, Della Torre G, Lavarino C, et al. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4containing amplicons at 12q1322［J］. J Pathol, 1998,185(2):188190.
［6］Hostein I, Coindre JM, Derre J, et al. Comparative genomic hybridization study of paraffinembedded dedifferentiated liposarcoma fixed with Holland Bouin's fluid［J］. Diagn Mol Pathol, 2003, 12(3):166173.
［7］Szymanska J, Tarkkanen M, Wiklund T, et al. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization［J］. Genes Chromosomes Cancer, 1996,15(2):8994.
［8］Weng WH, Wejde J, Ahlen J,et al. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH［J］. Cancer Genet Cytogenet, 2004, 150(1):2732.
［9］Ohguri T, Hisaoka M, Kawauchi S, et al. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by arraybased comparative genomic hybridisation［J］. J Clin Pathol, 2006, 59(9):978983.
［10］Tarkkanen M, Larramendy ML, Bohling T, et al. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and CMYC expression by immunohistochemistry［J］. Europ J Cancer, 2006, 42(8):11721180.
［11］Idbaih A, Coindre JM, Derre J,et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances［J］. Lab Invest, 2005, 85(2):176181.
［12］Dbaih A, Coindre JM, Derre J, et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances［J］. Lab Invest, 2005, 85(2):176181.
［13］Larramendy ML, Gentile M, Soloneski S,et al. Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma?［J］. Cancer Genet Cytogenet, 2008,187(1):111.
［14］Larramendy ML, Tarkkanen M, Blomqvist C, et al. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker［J］. Am J Pathol, 1997, 151(4):11531161.
［15］Weng WH, Ahlen J, Lui WO, et al. Gain of 17q in malignant fibrous histiocytoma is associated with a longer diseasefree survival and a low risk of developing distant metastasis［J］. Br J Cancer, 2003, 89(4):720726.
［16］MezaZepeda LA, Kresse SH, BarraganPolania AH, et al. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas［J］.Cancer Res, 2006, 66(18):89848993.
［17］EI Rifai W, Sarlomo Rikala M, Knuutila S, et al. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues［J］. Am J Pathol, 1998, 153(3):985990.
［18］Parente F, Grosgeorge J,Coindre JM, et al. Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors［J］. Cancer Genet Cytogenet, 1999,115(2):8995.
［19］Larramendy ML, Kaur S, Svarvar C, et al. Gene copy number profiling of softtissue leiomyosarcomas by arraycomparative genomic hybridization［J］. Cancer Genet Cytogenet, 2006, 169(2):94101.
［20］Mittal KR, Chen F, Wei JJ,et al.Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyomalike areas［J］.Mod Pathol, 2009, 22(10):13031311.
［21］Szymanska J,Serra M, Skytting B,et al. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization［J］. Genes Chromosomes Cancer, 1998, 23(3):213219.
［22］Nakagawa Y,Numoto K, Yoshida A, et al. Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization［J］. J Cancer Res Clin Oncol, 2006, 132(7):444450.
［23］Skytting BT, Szymanska J, Aalto Y, et al. Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization［J］. Cancer Genet Cytogenet, 1999,115 (1):3946.
［24］Tarkkanen M, Kiuru Kuhlefelt S, Blonquvist C, et al. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors［J］. Cancer Genet Cytogenet, 1999, 114 (1):3541.
［25］Ferreira BI, Alonso J, Carrillo J,et al. Array CGH and geneexpression profiling reveals distinct genomic instability patterns associated with DNA repair and cellcycle checkpoint pathways in Ewing’s sarcoma［J］.Oncogene, 2008, 27(14):20842090.
［26］Maurici D, PerezAtayde A, Grier HE, et al. Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma［J］. Cancer Genet Cytogenet, 1998, 100 (2):106110.
［27］Brisset S, Schleiermacher G, Peter M, et al. CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases［J］. Cancer Genet Cytogenet, 2001,130(1):5761.
［28］Ozaki T, Paulussen M, Poremba C, et al. Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors［J］. Genes Chromosomes Cancer, 2001, 32(2):164171.
［29］Armengol G, Tarkkanen M, Virolainen M, et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization［J］. Br J Cancer, 1997, 75(10):14031409.
［30］Nakagawa Y, Yoshida A, Numoto K, et al. Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization［J］. Oncol Rep, 2006, 15(2):297303.
［31］KiuruKuhlefelt S, ElRifai W, SarlomoRikala M, et al. DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study［J］. Mod Pathol, 1998, 11(3):227231.
［32］Lee MW, Jee KJ, Han SS, et al. Comparative genomic hybridization in epithelioid sarcoma［J］. Br J Dermatol, 2004,151(5):10541059.
［33］Lee MW, Jee KJ, Ro JY, et al. Proximaltype epithelioid sarcoma: case report and result of comparative genomic hybridization［J］. J Cutan Pathol, 2004, 31(1):6771.
［34］Linn SC, West RB, Pollack JR, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans［J］. Am J Pathol, 2003, 163(6):23832395.
［35］Bovee JV, CletonJansen AM, Rosenberg C, et al. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis［J］. J Pathol, 1999, 189(4):454462.
［36］Larramendy ML, Tarkkanen M, Valle J, et al. Gains, losses and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas［J］. Am J Pathol, 1997, 150 (2):685691.
［37］Hameed M, Ulger C, Yasar D, et al. Genome profiling of chondrosarcoma using oligonucleotide arraybased comparative genomic hybridization［J］.Cancer Genet Cytogenet, 2009, 192(2):5659.
［38］Miettinen MM, ElRifai W, SarlomoRikala M, et al. Tumor sizerelated DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas［J］. Mod Pathol, 1997, 10(12):11941200.
［39］Morawietz L, Kuhnen C, Katenkamp D, et al. Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma［J］. Virchows Arch, 2005,447 (6):990995.
［40］Meng GZ, Zhang HY, Zhang Z, et al. Myofibroblastic sarcoma vs nodular fasciitis: a comparative study of chromosomal imbalances［J］.Am J Clin Pathol, 2009, 131(5):701709. |
